摘要
大剂量化疗后予自体造血干细胞移植可提高多发性骨髓瘤患者的缓解率和生存率，低危患者行自体造血干细胞移植已逐渐取代传统的化疗，成为65岁以下初治多发性骨髓瘤患者的标准一线治疗手段。而多发性骨髓瘤患者自体造血干细胞移植的护理是治疗成功的关键。
Autologous hematopoietic stem cell transplantation can improve the remission rate and survival rate of patients with multiple myeloma who were treated with large doses of chemotherapy, and for low-risk patients, viable autologous hematopoietic stem cell transplantation has gradually replaced the traditional chemotherapy and became the standard first-line treatment for newly diagnosed multiple myeloma patients under the age of 65. Autologous hematopoietic stem cell transplantation in patients with multiple myeloma is the key to the success of treatment.
出处
《中华现代护理杂志》
2016年第36期5284-5285,共2页
Chinese Journal of Modern Nursing
关键词
护理
多发性骨髓瘤
自体造血干细胞移植
Nursing care
Multiple myeloma
Autologous stem cell transplantation
